Supporting Primary Care in Diagnosis and Choice of Treatment for Patients With Psychosocial Symptoms: SGEPsyScan.
SGE-PsyScan
1 other identifier
interventional
336
1 country
1
Brief Summary
Although effective treatments for psychosocial symptoms and disorders are available, patients frequently do not receive the most appropriate and effective treatment for their symptoms because of inappropriate and unstructured diagnostics of psychosocial symptoms in general practice. The hypothesis is that by using the intervention SGE-PsyScan the clinical symptoms of patients can be assessed more uniformly and earlier as opposed to the GPs' assessment in usual care. As a result, patients are supposed to start earlier with a treatment that fits the type and severity of their symptoms better. The patients will be randomly assigned to either receive the SGE-PsyScan or usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 11, 2013
CompletedFirst Posted
Study publicly available on registry
October 29, 2013
CompletedStudy Start
First participant enrolled
December 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedDecember 22, 2015
December 1, 2015
1.8 years
October 11, 2013
December 21, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
The rate of patients who achieve a successful decrease in the level of psychosocial symptoms as measured with the Symptom Checklist 90 (SCL-90) after 12 months. A successful treatment result is defined as a decrease in the SCL-90 patient score of 50%.
12 months
Secondary Outcomes (13)
The level of psychosocial symptoms of patients as measured with the SCL-90
3 months
The level of psychosocial symptoms of patients as measured with the SCL-90
6 months
Health technology assessment
3 months
Health technology assessment
6 months
Health technology assessment
9 months
- +8 more secondary outcomes
Other Outcomes (1)
Health care provider satisfaction with the Assessment of Chronic Illness Care (ACIC)
12 months
Study Arms (2)
SGE-PsyScan
EXPERIMENTALThe SGE-PsyScan is an internet application to which the General Practitioner (GP) refers the patient, which includes the distress screener, the 4-Dimensional Symptom Questionnaire (4DSQ) and a series of additional questions for differentiating between stress, depressive, anxious and somatization symptoms. Based on the 4DSQ patients and GPs receive advices for possible treatments.
Usual care
NO INTERVENTIONUsual care for persons with psychosocial symptoms and disorders in Dutch primary care includes all usual care procedures; preventive, screening, diagnostic, (non-)pharmacological or therapeutic procedures which are routinely used in everyday care.
Interventions
Eligibility Criteria
You may qualify if:
- Patients with (suspected) psychosocial symptoms
- Aged 18 years or older and capacitated
- Adequate understanding of Dutch language
- Able to perform SGE-PsyScan at home, individually
You may not qualify if:
- Clear and treatable somatic causes of symptoms
- Acute distress/danger
- No written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Maastricht University Medical Centerlead
- Stichting Gezondheidscentra Eindhoven (SGE)collaborator
- Stichting Volksgezondheidszorg (VGZ)collaborator
- Zorgverzekeraar CZcollaborator
Study Sites (1)
Stichting Gezondheidscentra Eindhoven
Eindhoven, 5605 LS, Netherlands
Related Publications (1)
Gidding LG, Spigt M, Winkens B, Herijgers O, Dinant GJ. PsyScan e-tool to support diagnosis and management of psychological problems in general practice: a randomised controlled trial. Br J Gen Pract. 2018 Jan;68(666):e18-e27. doi: 10.3399/bjgp17X694109. Epub 2017 Dec 18.
PMID: 29255109DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Mark G Spigt, PhD
Research Institute CAPHRI, Department of Family Medicine, Maastricht University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 11, 2013
First Posted
October 29, 2013
Study Start
December 1, 2013
Primary Completion
September 1, 2015
Study Completion
September 1, 2015
Last Updated
December 22, 2015
Record last verified: 2015-12